Sentences with phrase «treatment study involving»

The present study examined the prospective relationship between obsessive — compulsive and depressive symptoms during a multimodal treatment study involving youth with obsessive — compulsive disorder (OCD).

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Many of the things he said, the way he said them... he did not study the same as I did for certain, and anyone who believes they converse with god, should not be involved with anyone elses treatment.

Studies reported by The American Pregnancy Association suggest that the most effective fertility treatments involve a combination of acupuncture, herbal medicine, and traditional medical interventions.

For each treatment option, there will be a description of the various steps involved, information about medications, and links to further information, studies and research.

In addition, the probiotics studied were used alone or in combination with other probiotics (and in 1 study a prebiotic) and 9 studies involved a combination of prenatal (last 2 — 6 weeks of pregnancy) and maternal postnatal (6 — 24 months) treatment.

In the published studies I uncovered, effective treatment involved a concentrated topical solution ranging from 5 - 100 % concentration.

Note that toxicity studies of medication usually require treatment with huge doses over periods of time involving most or all of the animal's lifetime.

The study involved 19 people who had depression that had not been helped by conventional treatments.

Until recently, most studies examining oxytocin treatment for autism have used small sample sizes and involved only one or two hits of the hormone.

«The search for treatments that slow the progression of neurodegenerative diseases has gradually shifted from ameliorating symptoms to finding agents that reduce the progression of the disease,» said Gary Lynch, PhD, who studies neurodegeneration at the University of California, Irvine, and was not involved with this study.

Two of his studies influenced 2009 treatment guidelines from the European Society of Cardiology, which recommended the use of β - blockers in «patients undergoing surgery that doesn't directly involve the heart.»

The trial, a phase 3 study involving major cancer research institutions in Europe, the United States, Australia and Japan, enrolled 800 patients with metastatic colorectal cancer that was progressing despite previous treatment.

Sheba Meymandi, a professor of medicine at the University of California Los Angeles, and the director of the Center of Excellence for the Diagnosis and Treatment of Chagas Disease who was not involved in the study, had a different take on the results.

Their studies on mice revealed that the treatment did indeed reduce the swelling of the aorta and reduced levels of an enzyme that can break down the vascular wall and a protein involved in inflammatory processes.

«Studies like the current one involving rhabdomyosarcoma are giving us a close - up look at the way cancer evolves in response to treatment,» said study co-author Richard K. Wilson, Ph.D., director of The Genome Institute at Washington University School of Medicine in St. Louis, where scientists have extensive expertise analyzing tumor recurrence using whole - genome sequencing.

The study, involving 64 wastewater treatment plants across Switzerland, was commissioned by the Federal Office for the Environment.

The study (abstract 3.034) involves 261 people, predominantly children, who have severe epilepsy that had not responded adequately to other treatments.

A study involving Ottawa and Taiwan researchers, published in the journal Proceedings of the National Academy of Sciences (PNAS), provides new insight into why ovarian cancer is often resistant to chemotherapy, as well as a potential way to improve its diagnosis and treatment.

Professor Tamar Pincus, said: «Our study found that CCBT is acceptable to patients, but interestingly many patients who took part, as well as several of the clinicians involved — both psychologists and physiotherapists — thought the best treatment was a combination of both physiotherapy and CCBT.

«One - size treatment for blood cancer probably doesn't fit all, researchers say: Most multiple myeloma studies involve people of European descent, but the disease is more likely to affect African - Americans.»

Other postdocs are involved with smoking studies, alcohol studies, and drug treatment (e.g., voucher incentive) studies.

The study involved 58 precision medicine treatment arms and 293 that did not.

Future studies about romantic attachment will focus on using the findings from research such as Young's and Diamond's to develop new treatments for grief associated with partner separation or loss and for disorders that involve social deficits, such as schizophrenia and autism.

One month after the study treatment — which involves chemotherapy followed by intravenous infusion of JCAR017 — follow - up imaging showed complete remission of the brain lesion.

The study involved 23 patients with relapsed or treatment - resistant HL, a cancer of white blood cells called lymphocytes.

The study involved 871 patients from 72 primary care practices in England who were randomly assigned to 1 of 4 advice strategies: usual care, daily nasal and saline irrigation supported by a demonstration video, daily steam inhalation, or combined treatment with both interventions.

While there have been advances in early detection and many studies involving the treatment of children with ASD, few efforts to date have focused on interventions for adults.

«It's an exciting finding because those patients are the ones we have very few treatment options for,» says Jennifer Long, a voice doctor and scientist at the University of California, Los Angeles, head and neck surgery department, who wasn't involved in the study.

«Self - administered treatment for keloid scars can reduce the economic burden on the healthcare system and provide a treatment option for patients who have limited access to medical care,» comments Professor Jeffrey Karp from Brigham and Women's Hospital at Harvard Medical School, US, an expert on medical device design who was not involved in this study.

A study conducted by researchers from the University of Zurich, Zurich University Hospital and the University Hospital of Psychiatry Zurich now reveals that the successful treatment of an anxiety disorder alters key brain structures that are involved in processing and regulating emotions.

«Our study suggests some treatment involving the alpha1 - antitrypsin pathway might be able to make important modification of height in growth disorders.

The new study involved 72 patients, all of whom had received at least two prior lines of therapy and whose disease had relapsed and no longer responded to treatment.

«A better understanding of individual susceptibility to dental disease and variation in treatment outcomes will allow the dental field to move forward,» says Alexandre Vieira, a researcher involved in the study.

The study, which is published today in the Journal of Clinical Hypertension and is supported by Barts Charity, devised a novel treatment strategy for 55 patients, involving fractional dosing with tablets (halving or quartering pills), liquid formulations of antihypertensive drugs and patch formulations of antihypertensive drugs — plus use of unlicensed drugs that lower blood pressure.

In an efficacy study involving nonhuman primates that was specifically designed to evaluate the efficacy of AVI - 7288 after delayed treatment, a dose of 15 mg per kilogram per day for 14 days starting at 24, 48, and 96 hours after viral challenge provided 83 %, 100 %, and 83 % protection, respectively.

A study by the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has found new interactions between two molecules involved in acute myeloid leukemia (AML), STAT3 and PRL - 3, which may offer a new therapeutic target for cancer treatment.

Barré - Sinoussi, who shared a Nobel prize in 2008 for the co-discovery of HIV as the virus that causes AIDS, says studying the men could lead to new treatments that do not involve transplants.

These findings also suggest a mechanistic basis for potential treatments involving the painless electrical stimulation of the amygdala, which are currently being studied in ongoing clinical trials.

«The behavioral measures give you perspective on whether a treatment could actually work in helping improve the communicative abilities of older adults, while biological or auditory electrophysiology measures give you an indication of the actual mechanistic pathways that the training may be affecting,» says Frank Lin, an otolaryngologist at Johns Hopkins University in Baltimore, Maryland, who was not involved in the study.

«We can't start talking about improved treatments for Maya because diabetes is a very complex disease, involving lots of yet unknown risk factors, says Teresa Tusié Luna, a human geneticist who studies diabetes at the Salvador Zubirán National Institute of Health Sciences and Nutrition in Mexico City.

Other researchers noted that because the trial involved treatments that were all considered «standard of care,» it wasn't clear whether researchers needed to inform parents about risks related to care that might have been provided even without the study.

«We believe that behavioral activation is a good first step in treatment, and this article addresses that point,» says Weill Cornell Medical College geriatric psychiatrist George Alexopoulos, who was not involved in the study.

«Our study found that, at the population level, treatment strategies involving bevacizumab prolonged survival in patients with progressive glioblastoma.»

The study involved taking fingerprints from a group of patients seeking treatment at drug rehabilitation centres, as well as a larger group not known to be drug users.

The pilot study in the Netherlands using a paper version of the game involved 95 students with an average age of 16, randomly divided into treatment and control.

The researchers are also studying other molecules in the brain that are involved in depression and treatment response, and are recruiting people for further brain - scanning studies; see http://umhealth.me/placebodep for more information.

Strollo led a large study of the new treatment, a yearlong safety and efficacy trial involving 126 people with moderate to severe obstructive apnea.

Instead, the team chose only studies that were placebo - controlled, used tDCS as a daily medical treatment, and involved at least 10 participants.

Their experiments provide clues about the neural circuits and signaling pathways involved in compulsive behavior and may provide a useful animal model for studying OCD and evaluating treatments.